Your Catalyst to a Lucrative Business
benefits of multiple-gene analysis and NGS is projected to have a positive impact on the market growth over
the next few years.
Browse Details of Report @ https://www.hexaresearch.com/research-report/liquid-biopsy-market
The market can be segmented on the basis of geography as North America, Latin America, Asia
Pacific, Europe, and MEA. Rising occurrence of cancer across the globe is a key factor driving the
market growth in most of these regions. Intense competition in the market and emergence of
companies in developing regions like Asia Pacific are also likely to boost the market growth in the
forthcoming years. In addition, government support for R&D activities and advancement of liquid
biopsy tests are contributing significantly to the growth. North America is anticipated to lead the
market, followed by Europe on account of regulatory approvals for commercialization of the tests and
support for the implementation of liquid biopsy by various organizations, such as American Society of
Clinical Oncology (ASCO).
Asia Pacific is expected to emerge highly lucrative due to rapidly expanding medical tourism industry
and presence of leading revenue-generating countries, such as India, China, and Japan. In addition, a
number of biotech firms have started product trials in China owing to lenient clinical trial regulations.
This has compelled companies to shift their bases from developed regions
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-
industry
Follow Us: